FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2303640659> ?p ?o ?g. }

• W2303640659 endingPage "1090" @default.
• W2303640659 startingPage "1081" @default.
• W2303640659 abstract "Dyslipidaemia is very common in patients with HIV infection, but current therapies are often suboptimal. Since niacin may cause insulin resistance and hepatotoxicity, it has generally been avoided in this setting.Non-diabetic male subjects (n=33) who had well-controlled HIV infection on antiretroviral therapy, fasting triglycerides > or =2.26 mmol/l and non-high density lipoprotein cholesterol (non-HDL-C) > or =4.66 mmol/l received escalating doses of extended-release niacin (ERN) up to 2,000 mg nightly for up to 44 weeks.Fourteen subjects (42%) had pre-diabetes at entry. Twenty-three subjects (70%) received the maximum dose, eight (24%) received 1,500 mg. Niacin was well-tolerated. Only four subjects (12%) discontinued study treatment. There were small increases in fasting glycaemia and insulin resistance estimated by the homeostasis model assessment, but insulin resistance measures from the 2-h oral glucose tolerance test only transiently worsened. No subject developed persistent fasting hyperglycaemia; one had persistently elevated 2-h glucose >11.1 mmol/l. There were no significant changes in serum transaminases or uric acid. At week 48, the median change in fasting lipid levels in mmol/l (interquartile range) were: total cholesterol -0.21 (-1.35, -0.05), HDL-C +0.013 (-0.03,+0.28), non-HDL-C -0.49 (-1.37,+0.08) and triglycerides -1.73 (-3.68, -0.72). Favourable changes in large HDL and large very low density lipoprotein particle concentration were observed by nuclear magnetic resonance spectroscopy.ERN in doses up to 2,000 mg daily was safe, well-tolerated and efficacious in HIV-infected subjects with atherogenic dyslipidaemia. Increases in glycaemia and insulin resistance tended to be transient." @default.
• W2303640659 created "2016-06-24" @default.
• W2303640659 creator A5001715762 @default.
• W2303640659 creator A5007939079 @default.
• W2303640659 creator A5013548423 @default.
• W2303640659 creator A5028669057 @default.
• W2303640659 creator A5046928489 @default.
• W2303640659 creator A5049227770 @default.
• W2303640659 creator A5055013057 @default.
• W2303640659 creator A5057449551 @default.
• W2303640659 creator A5066975903 @default.
• W2303640659 creator A5068181380 @default.
• W2303640659 creator A5088973456 @default.
• W2303640659 date "2006-11-01" @default.
• W2303640659 modified "2023-10-05" @default.
• W2303640659 title "Safety and Efficacy of Extended-Release Niacin for the Treatment of Dyslipidaemia in Patients with HIV Infection: Aids Clinical Trials Group Study A5148" @default.
• W2303640659 cites W1979102029 @default.
• W2303640659 cites W1988179941 @default.
• W2303640659 cites W1992488558 @default.
• W2303640659 cites W1996819821 @default.
• W2303640659 cites W2002615726 @default.
• W2303640659 cites W2003358339 @default.
• W2303640659 cites W2003813742 @default.
• W2303640659 cites W2017602185 @default.
• W2303640659 cites W2019863077 @default.
• W2303640659 cites W2026021678 @default.
• W2303640659 cites W2028737910 @default.
• W2303640659 cites W2031527939 @default.
• W2303640659 cites W2032200225 @default.
• W2303640659 cites W2049170123 @default.
• W2303640659 cites W2060210361 @default.
• W2303640659 cites W2074372816 @default.
• W2303640659 cites W2078529164 @default.
• W2303640659 cites W2079795589 @default.
• W2303640659 cites W2085719460 @default.
• W2303640659 cites W2088643134 @default.
• W2303640659 cites W2098558143 @default.
• W2303640659 cites W2100861855 @default.
• W2303640659 cites W2116404316 @default.
• W2303640659 cites W2117179212 @default.
• W2303640659 cites W2118964190 @default.
• W2303640659 cites W2119065130 @default.
• W2303640659 cites W2133795831 @default.
• W2303640659 cites W2157138119 @default.
• W2303640659 cites W2160234571 @default.
• W2303640659 cites W2160689800 @default.
• W2303640659 cites W2165040426 @default.
• W2303640659 cites W2165947313 @default.
• W2303640659 cites W2166168319 @default.
• W2303640659 cites W2167830505 @default.
• W2303640659 cites W2168784348 @default.
• W2303640659 cites W2327879948 @default.
• W2303640659 cites W2332883209 @default.
• W2303640659 cites W2334101799 @default.
• W2303640659 cites W2417707941 @default.
• W2303640659 cites W2607031541 @default.
• W2303640659 cites W4205718468 @default.
• W2303640659 cites W4238251256 @default.
• W2303640659 cites W4249526692 @default.
• W2303640659 doi "https://doi.org/10.1177/135965350601100802" @default.
• W2303640659 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2288649" @default.
• W2303640659 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17302378" @default.
• W2303640659 hasPublicationYear "2006" @default.
• W2303640659 type Work @default.
• W2303640659 sameAs 2303640659 @default.
• W2303640659 citedByCount "47" @default.
• W2303640659 countsByYear W23036406592012 @default.
• W2303640659 countsByYear W23036406592013 @default.
• W2303640659 countsByYear W23036406592014 @default.
• W2303640659 countsByYear W23036406592015 @default.
• W2303640659 countsByYear W23036406592016 @default.
• W2303640659 countsByYear W23036406592019 @default.
• W2303640659 countsByYear W23036406592020 @default.
• W2303640659 crossrefType "journal-article" @default.
• W2303640659 hasAuthorship W2303640659A5001715762 @default.
• W2303640659 hasAuthorship W2303640659A5007939079 @default.
• W2303640659 hasAuthorship W2303640659A5013548423 @default.
• W2303640659 hasAuthorship W2303640659A5028669057 @default.
• W2303640659 hasAuthorship W2303640659A5046928489 @default.
• W2303640659 hasAuthorship W2303640659A5049227770 @default.
• W2303640659 hasAuthorship W2303640659A5055013057 @default.
• W2303640659 hasAuthorship W2303640659A5057449551 @default.
• W2303640659 hasAuthorship W2303640659A5066975903 @default.
• W2303640659 hasAuthorship W2303640659A5068181380 @default.
• W2303640659 hasAuthorship W2303640659A5088973456 @default.
• W2303640659 hasBestOaLocation W23036406591 @default.
• W2303640659 hasConcept C119060515 @default.
• W2303640659 hasConcept C126322002 @default.
• W2303640659 hasConcept C134018914 @default.
• W2303640659 hasConcept C2777391703 @default.
• W2303640659 hasConcept C2778096610 @default.
• W2303640659 hasConcept C2778163477 @default.
• W2303640659 hasConcept C2779306644 @default.
• W2303640659 hasConcept C2780072125 @default.
• W2303640659 hasConcept C2780092750 @default.
• W2303640659 hasConcept C555293320 @default.
• W2303640659 hasConcept C71924100 @default.
• W2303640659 hasConcept C90924648 @default.

• next